DelveInsight's 'Antibody-drug Conjugates in Oncology Competitive Landscape – 2024' report provides comprehensive global coverage of ...

The following is a summary of “Altered B-cell, plasma cell and antibody immune profiles in blood of systemic mastocytosis,” ...

Amgen (NASDAQ:AMGN) today announced the presentation of positive top-line results from the Phase 3 MINT trial evaluating the ...

A method that recovers full-length, paired heavy- and light-chain variable regions of B cell receptor transcripts ... cryo-EM structure of human IgM complexed with CD5L to reveal their interaction.

Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts. Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, Massachusetts General ...

IGM stock crashed Tuesday after the biotech company scrapped development of a cancer drug and announced three of its executives stepped down.

IGM Biosciences Inc.’s stock tumbled 14% Tuesday, as analysts weighed in with dismay on the company’s pivot away from ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Doctors suggested putting Emily on a clinical trial for CAR T-cell therapy, an experimental treatment that had just been approved for paediatric patients by the US Food and Drug Administration.

Sickle cell crisis is a health complication of sickle cell disease, an inherited blood disorder. It usually causes severe pain, and it happens due to an acute blood cell reaction. Sometimes sickle ...

The CAR T-cells then recognise and attack the cancer cells. It is a possible treatment for children and adults with relapsed or refractory B cell acute lymphoblastic leukaemia (ALL). It is also a ...